Skip to main content
SpringerLink
Log in

Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment

  • Case Report
  • Published:
Journal of Medical Ultrasonics Aims and scope Submit manuscript

Abstract

Neuroendocrine carcinoma of the gallbladder is an uncommon disease. We present the case of a 45-year-old woman with a mass located in the gallbladder, whose diagnosis was based on contrast-enhanced ultrasound and magnetic resonance imaging. The tumor involved the liver and retroperitoneum, and was histopathologically confirmed by liver biopsy as a neuroendocrine tumor grade 3. The patient received chemotherapy with good response, followed by surgery with cholecystectomy and partial hepatectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40:1–18.

    Article  PubMed  Google Scholar 

  2. Frilling A, Modlin IM, Kidd M, et al. for the Working Group on Neuroendocrine Liver Metastases. Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol 2014;15:e8–21. www.thelancet.com/oncology.

  3. John BJ, Davidson BR. Treatment options for unresectable neuroendocrine liver metastases. Expert Rev Gastroenterol Hepatol. 2012;6:357–69.

    Article  CAS  PubMed  Google Scholar 

  4. Albores-Saavedra J, Henson DE. Tumors of the Gallbladder and Extrahepatic Bile ducts. Radiographics. 2002;22:387–413.

    Article  Google Scholar 

  5. Hamilton SR, Aaktonen LA. Pathology and genetics, tumors of the digestive system. WHO. 2000;214–6.

  6. Jamali M, Chetty R. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining. Endocr Pathol. 2008;19:282–8.

    Article  CAS  PubMed  Google Scholar 

  7. Dhall D, Mertens R, Bresee C, et al. Ki-67 proliferative index predicts progression-free survival of patients with well differentiated ileal neuroendocrine tumors. Hum Pathol. 2012;43:489–95.

    Article  CAS  PubMed  Google Scholar 

  8. Eltawil KM, Gustafsson BI, Kidd M, et al. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010;44:687–95.

    PubMed  Google Scholar 

  9. Iwao M, Nakamura M, Enjoji M, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit. 2001;7:746–50.

    CAS  PubMed  Google Scholar 

  10. Albores-Saavedra J, Molberg K, Henson DE. Unusual malignant epithelial tumors of the gallbladder. Semin Diagn Pathol. 1996;13:326–38.

    CAS  PubMed  Google Scholar 

  11. Maitra A, Tascilar M, Hruban RH, et al. Small cell carcinoma of the gallbladder. A clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol. 2001;25:595–601.

    Article  CAS  PubMed  Google Scholar 

  12. Yamamoto M, Nakajo S, Miyoshi N, et al. Endocrine cell carcinoma (Carcinoid) of the gallbladder. Am J Surg Pathol. 1989;13:292–302.

    Article  CAS  PubMed  Google Scholar 

  13. Bosl GJ, Yagoda A, Camara LL. Malignant carcinoid of the gallbladder: third reported case and review of the literature. J Surg Oncol. 1980;13:215–22.

    Article  CAS  PubMed  Google Scholar 

  14. Komminoth P, Arnold R, Capella C, et al. Neuroendocrine neoplasms of the gallbladder and extrahepatic bile ducts. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO Classification of Tumours of the Digestive System. Lyon: IARC Press; 2010. p. 274–6.

    Google Scholar 

  15. Lepage C, Ciccolallo L, De Angelis R, et al. European disparities in malignant digestive endocrine tumours survival. Int J Cancer. 2010;126:2928–34.

    CAS  PubMed  Google Scholar 

  16. Albores-Saavedra J, Nadji M, Henson DE, et al. Intestinal metaplasia of the gallbladder: a morphologic and immunocytochemical study. Hum Pathol. 1986;17:614–20.

    Article  CAS  PubMed  Google Scholar 

  17. Papotti M, Cassoni P, Sapino A, et al. Large cell neuroendocrine carcinoma of the gallbladder: report of two cases. Am J Surg Pathol. 2000;24:1424–8.

    Article  CAS  PubMed  Google Scholar 

  18. Wakiyama S, Yoshimura K, Shimada M, et al. Heterotopic gastric mucosa in a gallbladder with an anomalous union of the pancreatobiliary duct: a case report. Hepatogastroenterology. 1998;45:1488–91.

    CAS  PubMed  Google Scholar 

  19. Modlin IM, Lye KD, Kidd M. A 5-Decade Analysis of 13,715 Carcinoid Tumors. Cancer. 2003;97:934–59.

    Article  PubMed  Google Scholar 

  20. McDermott EW, Guduric B, Brennan MF. Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg. 1994;81:1007–9.

    Article  CAS  PubMed  Google Scholar 

  21. Rindi G, D’Adda T, Froio E, et al. Prognostic factors in gastrointestinal endocrine tumors. Endocr Pathol. 2007;18:145–9.

    Article  PubMed  Google Scholar 

  22. Jung EM, Ross CJ, Rennert J, et al. Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: first results. Clin Hemorheol Microcirc. 2010;46:89–99.

    CAS  PubMed  Google Scholar 

  23. Rickes S, Ocran KW, Gerstenhauer G, et al. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echoenhanced ultrasound. Dig Dis. 2004;22:81–6.

    Article  PubMed  Google Scholar 

  24. d’Assignies G, Fina P, Bruno O, et al. High sensitivity of diffusion weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging. Radiology. 2013; 268:390–99.

  25. Frilling A, Sotiropoulos GC, Radtke A, et al. The impact of 68 Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg. 2010;252:850–6.

    Article  PubMed  Google Scholar 

  26. Ruf J, Heuck F, Schiefer J, et al. Impact of multiphase 68 Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors. Neuroendocrinology. 2010;91:101–9.

    Article  CAS  PubMed  Google Scholar 

  27. Elias D, Lefevre JH, Duvillard P, et al. Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: they are many more than you think. Ann Surg. 2010;251:307–10.

    Article  PubMed  Google Scholar 

  28. Bajetta E, Ferrari L, Martinetti A, et al. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer. 1999;86:858–65.

    Article  CAS  PubMed  Google Scholar 

  29. Seregni E, Ferrari L, Bajetta E, et al. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Ann Oncol. 2001;12:S69–72.

    Article  PubMed  Google Scholar 

  30. Soga J. Primary endocrinomas (carcinoid and variant neoplasm) of the gallbladder. A Statistical evaluation of 138 reported cases. J Exp Clin Cancer Res. 2001;22:5–15.

    Google Scholar 

  31. Pavel M, Baudin E, Couvelard A, et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012;95:157–76.

    Article  CAS  PubMed  Google Scholar 

  32. Sarmiento JM, Heywood G, Rubin J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197:29–37.

    Article  PubMed  Google Scholar 

  33. Elias D, Lasser P, Ducreux M, et al. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery. 2003;133:375–82.

    Article  PubMed  Google Scholar 

  34. Glazer ES, Tseng JF, Al-Refaie W, et al. Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford). 2010;12:427–33.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Iype S, Mirza TA, Propper DJ. Neuroendocrine tumours of the gallbladder: three cases and a review of the literature. Postgrad Med J. 2009;85:213–8.

    Article  CAS  PubMed  Google Scholar 

  36. Mitry E, Baudin E, Ducreux M, et al. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer. 1999;81:1351–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Moertel CG, Kvols LK, O’Connell MJ, et al. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68:227–32.

    Article  CAS  PubMed  Google Scholar 

  38. Mezi S, Petrozza V, Schillaci O. Neuroendocrine tumors of the gallbladder: a case report and review of the literature. J Med Case Rep. 2011;5:334.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Liliana Chiorean thanks Doctor Mark Kidd from Yale University, USA, for his kind guidance and advice during manuscript preparation.

Conflict of interest

There are no financial or other relations that could lead to a conflict of interest.

Ethical standards

This article does not contain any studies with human or animal subjects performed by any of the authors.

Informed consent

Written informed consent was obtained from the patient for the publication of this manuscript and any accompanying images.

Author information

Authors and Affiliations

  1. Department of Ultrasonography, “Octavian Fodor” Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania

    Liliana Chiorean

  2. Department of Surgery, “Octavian Fodor” Institute of Gastroenterology and Hepatology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

    Adrian Bartos & Cornel Iancu

  3. Department of Oncology, “Prof. Dr. Ion Chiricuta” Institute of Oncology, Cluj-Napoca, Romania

    Doris Pelau & Dana Iancu

  4. Department of Oncology, “Prof. Dr. Ion Chiricuta” Institute of Oncology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

    Tudor Ciuleanu

  5. Department of Pathology, “Prof. Dr. Ion Chiricuta” Institute of Oncology, Cluj-Napoca, Romania

    Rares Buiga

  6. “Phoenix” Diagnostic Clinic, Bucharest, Romania

    Irinel Oancea & Angelica Mangrau

  7. Department of Ultrasonography, “Octavian Fodor” Institute of Gastroenterology and Hepatology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

    Radu Badea

Authors
  1. Liliana Chiorean
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adrian Bartos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Doris Pelau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dana Iancu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tudor Ciuleanu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rares Buiga
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Irinel Oancea
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Angelica Mangrau
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Cornel Iancu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Radu Badea
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Bartos.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiorean, L., Bartos, A., Pelau, D. et al. Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment. J Med Ultrasonics 42, 271–276 (2015). https://doi.org/10.1007/s10396-014-0585-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10396-014-0585-1

Keywords

Search

Navigation